Endovascular stroke treatment today

American Journal of Neuroradiology

Volumn 32, Issue 2, 2011, Pages 238-243

  Grunwald, Iris Quasar ^a,b,c   Wakhloo, A K ^d   Walter, S ^e   Molyneux, A J ^b   Byrne, J V ^b   Nagel, S ^c,f   Kuhn A L ^g   Papadakis, M ^c   Fassbender, K ^e   Balami, J S ^c   Roffi, M ^h   Sievert, H ⁱ   Buchan, A ^c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^e SAARLAND UNIVERSITY   (Germany)

^f UNIVERSITY OF HEIDELBERG   (Germany)

^g CENTRE HOSPITALIER DE LUXEMBOURG   (Luxembourg)

^h UNIVERSITY HOSPITAL   (Switzerland)

ⁱ CardioVascular Center Frankfurt   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; DESMOTEPLASE; HEPARIN; PLACEBO; PROUROKINASE;

ADJUVANT THERAPY; BLEEDING; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; EMERGENCY TREATMENT; FIBRINOLYTIC THERAPY; HUMAN; MECHANICAL THROMBECTOMY; MORTALITY; PERCUTANEOUS THROMBECTOMY; RANDOMIZED CONTROLLED TRIAL; RANKIN SCALE; RECANALIZATION; REVIEW; STENT;

ACUTE DISEASE; BRAIN ISCHEMIA; HUMANS; STROKE; THROMBECTOMY; THROMBOLYTIC THERAPY;

EID: 79951588910     PISSN: 01956108     EISSN: 1936959X     Source Type: Journal    
DOI: 10.3174/ajnr.A2346     Document Type: Review

References (42)

1. NINDS rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-87
2. Heuschmann PU, Berger K, Misselwitz B, et al. Frequency of thrombolytic therapy in patients with acute ischemic stroke and the risk of in-hospital mortality: the German Stroke Registers Study Group. Stroke 2003;34:1106-13
3. Schumacher HC, Bateman BT, Boden-Albala B, et al. Use of thrombolysis in acute ischemic stroke: analysis of the Nationwide Inpatient Sample 1999 to 2004. Ann Emerg Med 2007;50:99-107
4. Weimar C, Kraywinkel K, Maschke M, et al. Intravenous thrombolysis in German stroke units before and after regulatory approval of recombinant tissue plasminogen activator. Cerebrovasc Dis 2006;22:429-31 (Pubitemid 44681120)
5. Albers GW, Thijs VN, Wechsler L, et al, for the DEFUSE Investigators. Magnetic resonance imaging profiles predict clinical response to early reperfusion: the Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution (DEFUSE) study. Ann Neurol 2006;60:508-17 (Pubitemid 44871793)
6. Davis SM, Donnan GA, Parsons MW, et al, for the EPITHET Investigators. Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol 2008;7:299-309. Epub 2008 Feb 28
7. Furlan AJ, Eyding D, Albers GW, et al, for the DEDAS Investigators. Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset. Stroke 2006;37:1227-31 (Pubitemid 43731867)
8. Hacke W, Albers G, Al-Rawi Y, et al, for the DIAS Study Group. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 2005;36: 66-73 (Pubitemid 40054177)
9. Warach S, for the DIAS-2 Study Group. Clinical benefit of desmoteplase treatment in patients with moderate to severe stroke: further results of the DIAS-2 Study. In: Proceedings of the International Stroke Conference, New Orleans, Louisiana. February 21, 2008
10. Mishra NK, Albers GW, Davis SM, et al. Mismatch-based delayed thrombolysis: a meta-analysis. Stroke 2010;41:e25-33. Epub 2009 Nov 19
11. Donnan GA, Baron JC,MaH, et al. Penumbral selection of patients for trials of acute stroke therapy. Lancet Neurol 2009;8:261-69
12. Zivin JA, Fisher M, De Girolami U, et al. Tissue plasminogen activator reduces neurological damage after cerebral embolism. Science 1985;230:1289-92 (Pubitemid 16194539)
13. Papadakis M, Buchan AM. Translational vehicles for neuroprotection. Biochem Soc Trans 2006;34:1318-22 (Pubitemid 46769047)
14. Qureshi Al, Ali Z, Suri MF, et al. Intra-arterial third generation recombinant tissue plasminogen activator (reteplase) for acute ischemic stroke. Neurosurgery 2001;49:41- 48, discussion 48-50
15. Hacke W, Kaste M, Fieschi C, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: The European Cooperative Acute Stroke Study (ECASS). JAMA 1995;274:1017-25
16. Hacke W, Kaste M, Fieschi C, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II): Second European-Australasian Acute Stroke Study Investigators. Lancet 1998;352:1245-51 (Pubitemid 28470336)
17. Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008;359:1317-29
18. Wahlgren N, Ahmed N, Davalos A, et al, for the SITS Investigators. Thrombolysis with alteplase 3-4.5 h after acute ischaemic stroke (SITS-ISTR): an observational study. Lancet 2008;372:1303-09
19. IMS Study Investigators. Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study. Stroke 2004;35:904-11. Epub 2004 Mar 11
20. Flaherty ML, Woo D, Kissela B, et al. Combined IV and intra-arterial thrombolysis for acute ischemic stroke. Neurology 2005;64:386-88
21. Lee KY, Kim DI, Kim SH, et al. Sequential combination of intravenous recombinant tissue plasminogen activator and intra-arterial urokinase in acute ischemic stroke. AJNR Am J Neuroradiol 2004;25:1470-75 (Pubitemid 44383595)
22. Lewandowski C, Frankel M, Tomsick T, et al, for the EMS Bridging Trial Investigators. Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial. Stroke 1999;30:2598-605
23. Zaidat OO, Suarez JI, Santillan C, et al. Response to intra-arterial and combined intravenous and intra-arterial thrombolytic therapy in patients with distal internal carotid artery occlusion. Stroke 2002;33:1821-26 (Pubitemid 34761068)
24. Del Zoppo GJ, Higashida RT, Furlan AJ, et al. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke - PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism. Stroke 1998;29:4-11 (Pubitemid 28046933)
25. Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke: The PROACT II study - a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999;282:2003-11
26. Smith W, Sung G, Saver J, et al. Mechanical thrombectomy for acute ischemic stroke: final results of the Multi Merci trial. Stroke 2008;39:1205-12. Epub 2008 Feb 28 (Pubitemid 351440692)
27. Mattle HP, Arnold M, Georgiadis D, et al. Comparison of intraarterial and intravenous thrombolysis for ischemic stroke with hyperdense middle cerebral artery sign. Stroke 2008;39:379-83 (Pubitemid 351619459)
28. The IMS II Trial Investigators. The Interventional Management of Stroke (IMS) II study. Stroke 2007;38:2127-35. Epub 2007 May 24
29. Tomsick T, Broderick J, Carrozella J, et al, for the Interventional Management of Stroke II Investigators. Revascularization results in the Interventional Management of Stroke II trial. AJNR Am J Neuroradiol 2008;29:582-87 (Pubitemid 351424079)
30. Mazighi M, Serfaty JM, Labreuche J, et al. Comparison of intravenous alteplase with a combined intravenous-endovascular approach in patients with stroke and confirmed arterial occlusion (RECANALISE study): a prospective cohort study. Lancet Neurol 2009;8:802-09
31. Gobin YP, Starkman S, Duckwiler GR, et al. Merci 1: a phase 1 study of mechanical embolus removal in cerebral ischemia. Stroke 2004;35:2848-54
32. Brekenfeld C, Schroth G, El-Koussy M, et al. Mechanical thromboembolectomy for acute ischemic stroke: comparison of the catch thrombectomy device and the Merci retriever in vivo. Stroke 2008;39:1213-19. Epub 2008 Feb 28 (Pubitemid 351440693)
33. Smith WS, Tsao JW, Billings ME, et al. Prognostic significance of angiographically confirmed large vessel intracranial occlusion in patients presenting with acute brain ischemia. Neurocrit Care 2006;4:14-17 (Pubitemid 43269455)
34. Smith WS, Sung G, Starkmann S, et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 2005;36:1432-38 (Pubitemid 40967507)
35. Smith WS. Intra-arterial thrombolytic therapy for acute basilar occlusion: pro. Stroke 2007;38:701-03 (Pubitemid 46188250)
36. Liebig T, Reinartz J, Hannes R, et al. Comparative in vitro study of five mechanical embolectomy systems: effectiveness of clot removal and risk of distal embolization. Neuroradiology 2008;50:43-52
37. Bose A, Henkes H, Alfke K, et al, for the Penumbra Phase 1 Stroke Trial Investigators. The Penumbra system: a mechanical device for the treatment of acute stroke due to thromboembolism. AJNR Am J Neuroradiol 2008;29:1409-13
38. The Penumbra Pivotal Stroke Trial Investigators. The Penumbra pivotal stroke trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke 2009;40:2761-68. Epub 2009 Jul 9
39. Grunwald IQ, Bose A, Struffert T, et al. Images in neurology: liposuction in mind. Arch Neurol 2009;66:800-01
40. Grunwald IQ, Walter S, Papanagiotou P, et al. Revascularization in acute ischaemic stroke using the Penumbra system: the first single center experience. Eur J Neurol 2009;16:1210-16
41. Nogueira RG, Yoo AJ, Buonanno FS, et al. Endovascular approaches to acute stroke. Part 2. A comprehensive review of studies and trials. AJNR Am J Neuroradiol 2009;30:859-75
42. Castaño C, Dorado L, Guerrero C, et al. Mechanical thrombectomy with the Solitaire AB device in large artery occlusions of the anterior circulation: a pilot study. Stroke 2010;41:1836-40. Epub 2010 Jun 10